Full abstracts accepted as poster presentations will also be included in the special CTAD edition of the Journal of Prevention of Alzheimer’s Disease (JPAD), the official journal of the CTAD ...

"We’re excited to present this new clinical data at CTAD, which demonstrates the potential of Spectris™ to preserve both ...

Patients with MS showed half the rate of amyloid pathology compared with people without MS, suggesting a possible protective effect against Alzheimer's disease.

Oct. 3, 2024 — An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time, scientists have developed a ...

Boosting a specific protein in the brain could help slow the progression of Alzheimer’s disease, a new study has found. The longstanding theory is that Alzheimer’s occurs when a protein called ...

Have we been wrong about what causes Alzheimer's disease? New research suggests yes. For years, the leading theory for the cause of this neurodegeneration was the accumulation of abnormal proteins ...

Here’s our process. There are plenty of products available to help make everyday life easier for people with Alzheimer’s disease. These assistive products are simple, affordable, and easy to find.

GT-02287 Demonstrates Disease Modifying Capacity in Both GBA1 and Idiopathic Parkinson’s Disease ModelsGT-02287 Improves Mitochondrial Function ...

Scientists may have uncovered a new mechanism for treating Alzheimer's disease, offering hope to millions of patients worldwide. The discovery involves the activation of the brain's cellular clean ...

Citation: New Alzheimer's studies reveal disease biology, risk for progression and the potential for a novel blood test (2024, September 18) retrieved 5 October 2024 from https://medicalxpress.com ...

Oct. 3, 2024 — An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time, scientists have developed a ...

Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, announced today it has been selected to present multiple poster presentations for its disea ...